This document summarizes a study that characterized mutations causing Glanzmann's thrombasthenia (GT) in Iranian patients. The study identified 3 novel mutations in 20 GT patients by analyzing their ITGA2B and ITGB3 genes encoding the platelet glycoprotein IIb/IIIa complex. Sequence analysis revealed frameshift mutations causing premature termination, as well as missense and synonymous polymorphisms. The various mutations were found to impair glycoprotein expression and function, thereby causing the impaired platelet aggregation that is characteristic of GT.